Kawaoka Y - Search Results

1

Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2.

Uwamino Y, Nagata M, Aoki W, Fujimori Y, Nakagawa T, Yokota H, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Shiraki T, Uchida S, Uno S, Kabata H, Ikemura S, Kamata H, Ishii M, Fukunaga K, Kawaoka Y, Hasegawa N, Murata M. Uwamino Y, et al. Among authors: kawaoka y. J Clin Pathol. 2021 Jan;74(1):67-68. doi: 10.1136/jclinpath-2020-206972. Epub 2020 Sep 14. J Clin Pathol. 2021. PMID: 32928941 No abstract available.

2

High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza.

Shiraishi K, Mitamura K, Sakai-Tagawa Y, Goto H, Sugaya N, Kawaoka Y. Shiraishi K, et al. Among authors: kawaoka y. J Infect Dis. 2003 Jul 1;188(1):57-61. doi: 10.1086/375799. Epub 2003 Jun 23. J Infect Dis. 2003. PMID: 12825171

3

Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.

Horimoto T, Takada A, Iwatsuki-Horimoto K, Hatta M, Goto H, Kawaoka Y. Horimoto T, et al. Among authors: kawaoka y. J Virol. 2003 Jul;77(14):8031-8. doi: 10.1128/jvi.77.14.8031-8038.2003. J Virol. 2003. PMID: 12829842 Free PMC article.

4

The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus.

Iwatsuki-Horimoto K, Kanazawa R, Sugii S, Kawaoka Y, Horimoto T. Iwatsuki-Horimoto K, et al. Among authors: kawaoka y. J Gen Virol. 2004 Apr;85(Pt 4):1001-1005. doi: 10.1099/vir.0.19519-0. J Gen Virol. 2004. PMID: 15039542

5

Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003.

Horimoto T, Fukuda N, Iwatsuki-Horimoto K, Guan Y, Lim W, Peiris M, Sugii S, Odagiri T, Tashiro M, Kawaoka Y. Horimoto T, et al. Among authors: kawaoka y. J Vet Med Sci. 2004 Mar;66(3):303-5. doi: 10.1292/jvms.66.303. J Vet Med Sci. 2004. PMID: 15107562

6

A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.

Horimoto T, Takada A, Iwatsuki-Horimoto K, Kawaoka Y. Horimoto T, et al. Among authors: kawaoka y. Vaccine. 2004 Jun 2;22(17-18):2244-7. doi: 10.1016/j.vaccine.2003.11.019. Vaccine. 2004. PMID: 15149783

7

Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.

Horimoto T, Iwatsuki-Horimoto K, Hatta M, Kawaoka Y. Horimoto T, et al. Among authors: kawaoka y. Microbes Infect. 2004 May;6(6):579-83. doi: 10.1016/j.micinf.2004.02.011. Microbes Infect. 2004. PMID: 15158192 Free article.

8

Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence.

Iwatsuki-Horimoto K, Horimoto T, Fujii Y, Kawaoka Y. Iwatsuki-Horimoto K, et al. Among authors: kawaoka y. J Virol. 2004 Sep;78(18):10149-55. doi: 10.1128/JVI.78.18.10149-10155.2004. J Virol. 2004. PMID: 15331747 Free PMC article.

9

Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y. Kiso M, et al. Among authors: kawaoka y. Lancet. 2004 Aug 28-Sep 3;364(9436):759-65. doi: 10.1016/S0140-6736(04)16934-1. Lancet. 2004. PMID: 15337401

10

Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor.

Hatakeyama S, Sakai-Tagawa Y, Kiso M, Goto H, Kawakami C, Mitamura K, Sugaya N, Suzuki Y, Kawaoka Y. Hatakeyama S, et al. Among authors: kawaoka y. J Clin Microbiol. 2005 Aug;43(8):4139-46. doi: 10.1128/JCM.43.8.4139-4146.2005. J Clin Microbiol. 2005. PMID: 16081961 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

952 results

Search Page